Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

SEC Filings

SEC Filings

Form Description Filing date View
REGDEX

REGDEX

View HTML
REGDEX

REGDEX

View HTML
D View HTML
D View HTML
D View HTML
S-1

Registration statement for face-amount certificate companies

View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

View HTML

Copyright Morningstar



Copyright 2017 - Stemline Therapeutics, Inc. All rights reserved